Diabetes drug shows promise for spinal cord injury in early trial
NCT ID NCT05426681
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests whether a common diabetes pill, glyburide, can safely protect the spinal cord from further damage after a traumatic injury. Researchers will enroll 12 adults with acute spinal cord injury to check safety and see if the drug helps preserve nerve function. The goal is to gather enough information to plan a larger study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40536, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Electric jolts to abdominal muscles may restore cough power after spinal injury
- New ultrasound method spots low blood flow in spinal cord injuries
- Spinal injury patients may keep stronger bones with simple infusion
- Experimental drug ALMB-0166 tested in spinal cord injury patients
- Spinal zaps could stop dizziness after injury